blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3427695

EP3427695 - A BLOOD FLOW CONTROLLING APPARATUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.12.2023
Database last updated on 04.06.2024
FormerThe patent has been granted
Status updated on  13.01.2023
FormerGrant of patent is intended
Status updated on  15.09.2022
FormerRequest for examination was made
Status updated on  19.07.2019
FormerThe application has been published
Status updated on  14.12.2018
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024 [2024/26]
Applicant(s)For all designated states
Edwards Lifesciences AG
Route de l'Etraz 70
1260 Nyon / CH
[2022/50]
Former [2019/03]For all designated states
Edwards Lifesciences AG
Chemin du Glapin 6
1162 St. Prex / CH
Inventor(s)01 / Jan Otto, Solem
Hulda Rasks v.12
23742 Bjarred / SE
 [2019/03]
Representative(s)Dolleymores
9 Rickmansworth Road
Watford, Hertfordshire WD18 0JU / GB
[2019/03]
Application number, filing date18178494.320.04.2006
[2019/03]
Priority number, dateSE2005000089121.04.2005         Original published format: SE 0500891
[2019/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3427695
Date:16.01.2019
Language:EN
[2019/03]
Type: B1 Patent specification 
No.:EP3427695
Date:15.02.2023
Language:EN
[2023/07]
Search report(s)(Supplementary) European search report - dispatched on:EP22.11.2018
ClassificationIPC:A61F2/24, A61B17/04
[2019/03]
CPC:
A61F2/2418 (EP,US); A61F2/2442 (US); A61F2/2403 (US);
A61F2/2412 (EP,SE,US); A61F2/2427 (US); A61F2/2457 (US);
A61F2/246 (EP,US); A61B2017/0412 (EP,US); A61F2/2466 (EP,US);
A61F2210/0014 (EP,US); A61F2220/0008 (EP,US); A61F2220/0016 (EP,US);
A61F2230/0054 (US); A61F2310/00017 (EP,US); A61F2310/00023 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/34]
Former [2019/03]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:BLUTFLUSSSTEUERUNGSVORRICHTUNG[2019/03]
English:A BLOOD FLOW CONTROLLING APPARATUS[2019/03]
French:APPAREIL DE CONTRÔLE DU FLUX SANGUIN[2019/03]
Examination procedure16.07.2019Amendment by applicant (claims and/or description)
16.07.2019Examination requested  [2019/34]
16.07.2019Date on which the examining division has become responsible
16.09.2022Communication of intention to grant the patent
04.01.2023Fee for grant paid
04.01.2023Fee for publishing/printing paid
04.01.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06724472.3  / EP1871300
EP16157166.6  / EP3056170
EP17156346.3  / EP3187150
Opposition(s)16.11.2023No opposition filed within time limit [2024/04]
Fees paidRenewal fee
27.06.2018Renewal fee patent year 03
27.06.2018Renewal fee patent year 04
27.06.2018Renewal fee patent year 05
27.06.2018Renewal fee patent year 06
27.06.2018Renewal fee patent year 07
27.06.2018Renewal fee patent year 08
27.06.2018Renewal fee patent year 09
27.06.2018Renewal fee patent year 10
27.06.2018Renewal fee patent year 11
27.06.2018Renewal fee patent year 12
27.06.2018Renewal fee patent year 13
18.04.2019Renewal fee patent year 14
21.04.2020Renewal fee patent year 15
15.04.2021Renewal fee patent year 16
16.03.2022Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
IT15.02.2023
LT15.02.2023
LV15.02.2023
MC15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SI15.02.2023
SK15.02.2023
IE20.04.2023
LU20.04.2023
BE30.04.2023
CH30.04.2023
LI30.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
[2024/26]
Former [2024/21]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
MC15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SI15.02.2023
SK15.02.2023
IE20.04.2023
LU20.04.2023
BE30.04.2023
CH30.04.2023
LI30.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2024/11]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
MC15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SI15.02.2023
SK15.02.2023
LU20.04.2023
BE30.04.2023
CH30.04.2023
LI30.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2024/09]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
MC15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SK15.02.2023
LU20.04.2023
CH30.04.2023
LI30.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2024/08]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
MC15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SK15.02.2023
LU20.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2024/04]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SK15.02.2023
LU20.04.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/50]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
SK15.02.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/49]AT15.02.2023
CZ15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
RO15.02.2023
SE15.02.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/48]AT15.02.2023
DK15.02.2023
EE15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
SE15.02.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/46]AT15.02.2023
DK15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
SE15.02.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/39]AT15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
SE15.02.2023
GR16.05.2023
IS15.06.2023
PT15.06.2023
Former [2023/38]AT15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
PL15.02.2023
SE15.02.2023
GR16.05.2023
PT15.06.2023
Former [2023/37]AT15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
SE15.02.2023
GR16.05.2023
PT15.06.2023
Former [2023/36]AT15.02.2023
ES15.02.2023
FI15.02.2023
LT15.02.2023
LV15.02.2023
NL15.02.2023
SE15.02.2023
PT15.06.2023
Former [2023/35]AT15.02.2023
ES15.02.2023
LT15.02.2023
NL15.02.2023
PT15.06.2023
Former [2023/34]ES15.02.2023
LT15.02.2023
PT15.06.2023
Former [2023/33]ES15.02.2023
LT15.02.2023
Documents cited:Search[A]WO9930647  (MYOCOR INC [US], et al) [A] 1-14 * page 7, line 4 - line 21; figure 9 ** page 9, line 22 - line 33; figure 21 *;
 [A]EP1472996  (MEDTRONIC VASCULAR INC [US]) [A] 1-14 * paragraph [0045] - paragraph [0048]; figure 9 * * paragraph [0045] - paragraph [0048] *;
 [XP]WO2005087140  (PERCUTANEOUS CARDIOVASCULAR SO [AU], et al) [XP] 1,2,5-7,9-14 * page 15, line 10 - page 16, line 2; figures 16-20 * * page 11, line 3 - line 11 *
by applicantUS6210432
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.